Solventum Welcomes Shirley Edwards to its Board

Solventum has named Shirley Edwards to its Board of Directors, serving on the Audit and Talent committees.
 
“We are excited to welcome Shirley to our Board of Directors. Her extensive expertise in mergers and acquisitions, corporate governance, performance enhancement, finance and human resources will serve as a valuable resource as Solventum advances its specialized growth and market strategies, along with capital allocation approaches,” Solventum CEO Bryan Hanson said.
 
From 2002 to 2022, Edwards was a partner at EY, culminating in her role as global client service partner from 2017 to 2022. Her career at EY was marked by significant leadership and client service roles, including the stewardship of EY’s nearly $4 billion assurance practice across 20 countries in the Americas, encompassing 10 regions and a team of more than 20,000 professionals. She was instrumental in driving the strategy for audit, forensics, and financial accounting and advisory services throughout the Americas. Beyond her professional achievements, Edwards has contributed her expertise as a board member and advisor to several organizations: the Girl Scouts of the Nation’s Capital, Leadership Greater Washington, the Pamplin College of Business Advisory Council at Virginia Tech, National Capital Region Advisory Board for the American Red Cross and currently, Appian Corporation and Cumming Group.

Edwards earned a bachelor of science degree in accounting from Virginia Tech.
 
“Shirley joins a robust board that brings deep expertise across healthcare, strategy and finance. We are ready to bring forward Solventum’s mission of enabling better, smarter, safer health care to improve lives,” Solventum Board Chair Carrie Cox stated.
 
Current Solventum board members include: Hanson; Cox, former Humacyte Inc. CEO; Susan D. DeVore, former Premier Inc. CEO; Glenn A. Eisenberg, executive vice president and chief financial officer, Laboratory Corporation of America Holdings; Dr. Bernard A. Harris Jr., former NASA astronaut, CEO and managing partner, Versalius Ventures Inc.; Karen J. May, former executive vice president and chief human resources officer, Mondelez International Inc.; Elizabeth A. Mily, former executive vice president, strategy and business development, Bristol-Myers Squibb; John H. Weiland, former president and chief operating officer, C.R. Bard Inc.; Amy A. Wendell former senior vice president, strategy and business development and licensing, Covidien; Darryl L. Wilson, former vice president, commercial, GE; and Carlos Albán, former vice chairman and chief commercial officer, AbbVie Inc.
 
Solventum is a new company that creates breakthrough solutions for our customers’ toughest challenges, pioneering innovations at the intersection of health, material, and data science.